Anti-itch Vulva Cream 1 Hydrocortisone Acetate
Hydrocortisone Acetate
The Honey Pot Company Llc
Human Otc Drug
NDC 82637-9455Anti-itch Vulva Cream 1 Hydrocortisone Acetate also known as Hydrocortisone Acetate is a human otc drug labeled by 'The Honey Pot Company Llc'. National Drug Code (NDC) number for Anti-itch Vulva Cream 1 Hydrocortisone Acetate is 82637-9455. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Anti-itch Vulva Cream 1 Hydrocortisone Acetate drug includes Hydrocortisone Acetate - 10 mg/mL . The currest status of Anti-itch Vulva Cream 1 Hydrocortisone Acetate drug is Active.
Drug Information:
| Drug NDC: | 82637-9455 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Anti-itch Vulva Cream 1 Hydrocortisone Acetate |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Hydrocortisone Acetate |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | The Honey Pot Company Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | HYDROCORTISONE ACETATE - 10 mg/mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Mar, 2022 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 15 Jan, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part348 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | The Honey Pot Company LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 1039349
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0850021589455
|
| UPC stands for Universal Product Code. |
| UNII: | 3X7931PO74
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
| Pharmacologic Class: | Corticosteroid Hormone Receptor Agonists [MoA]
Corticosteroid [EPC]
|
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 82637-9455-1 | 1 TUBE in 1 CARTON (82637-9455-1) / 30 mL in 1 TUBE | 01 Mar, 2022 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose anti-itch
Product Elements:
Anti-itch vulva cream 1 hydrocortisone acetate hydrocortisone acetate adansonia digitata seed oil allantoin aloe vera leaf shea butter c10-18 triglycerides candelilla wax caprylhydroxamic acid caprylyl glyceryl ether ceramide ng cetostearyl alcohol cetyl alcohol cholesterol citric acid monohydrate coconut oil diethylene glycol monoethyl ether glyceryl monostearate sunflower oil helianthus annuus seed wax hydroxyethyl cellulose, unspecified lavender oil limonene, (+)- linalool, (+/-)- azadirachta indica seed oil peppermint oil myristyl alcohol potassium sorbate propanediol propolis wax jojoba oil sodium benzoate phytate sodium sodium stearoyl lactylate steareth-30 stearic acid stearyl alcohol sucrose palmitate cocoa butter water xanthan gum hydrocortisone acetate hydrocortisone
Indications and Usage:
Uses: for the temporary relief of external feminine itching.
Warnings:
Warnings: for external use only when using this product: avoid contact with eyes. stop use and ask doctor if: condition worsens if symptoms persist for more than 7 days, or clear up and reoccur again within a few days do not use if: you have vaginal discharge. consult a physician. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away
Do Not Use:
Warnings: for external use only when using this product: avoid contact with eyes. stop use and ask doctor if: condition worsens if symptoms persist for more than 7 days, or clear up and reoccur again within a few days do not use if: you have vaginal discharge. consult a physician. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away
When Using:
When using this product: avoid contact with eyes.
Dosage and Administration:
Directions: adults and children 12 years of age and older: apply to affected area not more than 3 to 4 times daily. children under 12 years of age: consult a doctor
Stop Use:
Stop use and ask doctor if: condition worsens if symptoms persist for more than 7 days, or clear up and reoccur again within a few days
Package Label Principal Display Panel:
Package labeling: label inner_labek
Further Questions:
Questions: for questions and general information visit us at www.thehoneypot.co/contact